Assessments of Prostate Cancer Cell Functions Highlight Differences Between a Pan-PI3K/mTOR Inhibitor, Gedatolisib, and Single-Node Inhibitors of the PI3K/AKT/mTOR Pathway

Medicine, Urology, Oncology,
prostate cancer   PI3K/AKT/mTOR pathway   Gedatolisib   single-node inhibitors   cell functions  

Prostate Cancer Cell Function Assessments Reveal Differences Between Gedatolisib and Single-Node PI3K/AKT/mTOR Inhibitors Academic Background Prostate cancer (PC) is one of the most common cancers among men worldwide, particularly in advanced stages where patients often develop resistance to androgen deprivation therapy (ADT), progressing to castra...